CNBC Television published this video item, entitled “Jefferies’ Holz: Pfizer, Mylan deal not seen as defensive, both business in ‘tight spaces'” – below is their description.
Jared Holz, health care sector strategist at Jefferies, and Chris Meekins, research analyst at Raymond James, join CNBC’s “Closing Bell” to discuss the new deal between Pfizer and Mylan, as well as presidential hopeful Sen. Kamala Harris’ new healthcare plan.
CNBC Television YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.